Zheng-Fang Yi (Z Yi, Zhengfang Yi)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 21

Top Venues

Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University Dec 31 2015

China

Professor :: East China Normal University

Publications

Huang Chen, Aiwu Bian, Wenbo Zhou, Ying Miao, Jiangnan Ye, Jiahui Li, Peng He, Qiansen Zhang, Yue Sun, Zhenliang Sun, Chaowen Ti, Yihua Chen, Zheng-Fang Yi, Mingyao Liu
Discovery of the Highly Selective and Potent STAT3 Inhibitor for Pancreatic Cancer Treatment. ACS central science 10 (3) (2024)
Huang Chen, Aiwu Bian, Lian-Fang Yang, Xuan Yin, Jie Wang, Chaowen Ti, Ying Miao, Shihong Peng, Shifen Xu, Mingyao Liu, Wen-Wei Qiu, Zheng-Fang Yi
Correction: Targeting STAT3 by a small molecule suppresses pancreatic cancer progression. Oncogene (2024)
Huang Chen, Aiwu Bian, Wenbo Zhou, Ying Miao, Jiangnan Ye, Jiahui Li, Peng He, Qiansen Zhang, Yue Sun, Zhenliang Sun, Chaowen Ti, Yihua Chen, Zheng-Fang Yi, Mingyao Liu
Discovery of the Highly Selective and Potent STAT3 Inhibitor for Pancreatic Cancer Treatment. ACS central science 10 (3) (2024)
Haijun Gu, Ting Zhang, Tian Guan, Min Wu, Shen Li, Yunqi Li, Mengmeng Guo, Lin Zhang, Yangrui Peng, Dazhao Mi, Mingyao Liu, Zheng-Fang Yi, Yihua Chen
Discovery of a Highly Potent and Selective MYOF Inhibitor with Improved Water Solubility for the Treatment of Gastric Cancer. Journal of medicinal chemistry (2023)
Wangrui Jin, Tao Zhang, Wenbo Zhou, Peng He, Yue Sun, Shijia Hu, Huang Chen, Xinglong Ma, Yangrui Peng, Zheng-Fang Yi, Mingyao Liu, Yihua Chen
Discovery of 2-Amino-3-cyanothiophene Derivatives as Potent STAT3 Inhibitors for the Treatment of Osteosarcoma Growth and Metastasis. Journal of medicinal chemistry 65 (9) (2022)
Peng He, Ying Miao, Yue Sun, Aiwu Bian, Wangrui Jin, Huang Chen, Jiangnan Ye, Jia He, Yangrui Peng, Haijun Gu, Mingyao Liu, Zheng-Fang Yi, Yihua Chen
Discovery of a Novel Potent STAT3 Inhibitor HP590 with Dual p-Tyr 705 /Ser 727 Inhibitory Activity for Gastric Cancer Treatment. Journal of medicinal chemistry 65 (19) (2022)
Peng He, Aiwu Bian, Ying Miao, Wangrui Jin, Huang Chen, Jia He, Liting Li, Yue Sun, Jiangnan Ye, Mingyao Liu, Zheng-Fang Yi, Wenbo Zhou, Yihua Chen
Discovery of a Highly Potent and Orally Bioavailable STAT3 Dual Phosphorylation Inhibitor for Pancreatic Cancer Treatment. Journal of medicinal chemistry 65 (22) (2022)
Huang Chen, Wenbo Zhou, Aiwu Bian, Qiansen Zhang, Ying Miao, Shifen Xu, Jiangnan Ye, Shi-Fen Xu, Chaowen Ti, Zhenliang Sun, Jianghua Zheng, Yihua Chen, Mingyao Liu, Zheng-Fang Yi
Selectively targeting STAT3 using a small molecule inhibitor is a potential therapeutic strategy for pancreatic cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Qiu-Rui He, Jiang-Jiang Tang, Yao Liu, Zhi-Fan Chen, Yu-Xi Liu, Huang Chen, Ding Li, Zheng-Fang Yi, Jin-Ming Gao
The natural product trienomycin A is a STAT3 pathway inhibitor that exhibits potent in vitro and in vivo efficacy against pancreatic cancer. British journal of pharmacology 178 (12) (2021)
Huang Chen, Aiwu Bian, Lian-Fang Yang, Xuan Yin, Jie Wang, Chaowen Ti, Ying Miao, Shihong Peng, Shifen Xu, Mingyao Liu, Wen-Wei Qiu, Zheng-Fang Yi
Targeting STAT3 by a small molecule suppresses pancreatic cancer progression. Oncogene 40 (8) (2021)
Weikai Guo, Yajing Xing, Qiansen Zhang, Jiuqing Xie, Dongxia Huang, Haijun Gu, Peng He, Miaoran Zhou, Shi-Fen Xu, Xiufeng Pang, Mingyao Liu, Zheng-Fang Yi, Yihua Chen
Synthesis and Biological Evaluation of B-Cell Lymphoma 6 Inhibitors of N-Phenyl-4-pyrimidinamine Derivatives Bearing Potent Activities against Tumor Growth. Journal of medicinal chemistry 63 (2) (2020)
Pengju Zhang, You Li, Yaohui Tang, Hui Shen, Jiankai Li, Zheng-Fang Yi, Qinfei Ke, He Xu
Copper-Based Metal-Organic Framework as a Controllable Nitric Oxide-Releasing Vehicle for Enhanced Diabetic Wound Healing. ACS applied materials & interfaces 12 (16) (2020)
Shihong Peng, Jie Wang, Huang Chen, Pan Hu, Xiao-Long He, Yundong He, Minna Wang, Wenshu Tang, Qiurui He, Ying-Ying Wang, Jiayi Xie, Dandan Guo, Shancheng Ren, Mingyao Liu, Wen-Wei Qiu, Zheng-Fang Yi
Regression of castration-resistant prostate cancer by a novel compound QW07 targeting androgen receptor N-terminal domain. Cell biology and toxicology 36 (5) (2020)
Yuqi Jiang, You Li, Jiankai Li, Yiming Han, Pengju Zhang, Zheng-Fang Yi, Qinfei Ke, He Xu
A Mussel-Inspired Extracellular Matrix-Mimicking Composite Scaffold for Diabetic Wound Healing. ACS applied bio materials 3 (7) (2020)
Xiaocheng Wang, Fang Lv, Tian Li, Yiming Han, Zheng-Fang Yi, Mingyao Liu, Jiang Chang, Chengtie Wu
Correction to Electrospun Micropatterned Nanocomposites Incorporated with Cu2S Nanoflowers for Skin Tumor Therapy and Wound Healing. ACS nano 13 (3) (2019)
Ting Shao, Tingting Fan, Wenshu Tang, Yanting Sun, Song Gao, Huang Chen, Zhenliang Sun, Mingyao Liu, Zheng-Fang Yi
Ethyl-N-dodecanoyl-l-arginate hydrochloride combats pathogens with low-resistance generation by membrane attack and modifies gut microbiota structure. Microbial biotechnology 13 (3) (2019)
Yunqi Li, Yuan He, Ting Shao, Haixiang Pei, Weikai Guo, Dazhao Mi, Isabelle Krimm, Yuanjin Zhang, Pei-Li Wang, Xin Wang, Mingyao Liu, Zheng-Fang Yi, Yihua Chen
Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin. Journal of medicinal chemistry 62 (10) (2019)
T Shao, W Tang, Y Li, D Gao, K Lv, P He, Y Song, S Gao, M Liu, Yihua Chen, Zheng-Fang Yi
Research on function and mechanisms of a novel small molecule WG449E for hypertrophic scar. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (3) (2019)
Tao Zhang, Jingjie Li, Yuan He, Feifei Yang, Yun Hao, Wangrui Jin, Jing Wu, Zhenliang Sun, Yunqi Li, Yihua Chen, Zheng-Fang Yi, Mingyao Liu
A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer. Nature communications 9 (1) (2018)
Yundong He, Shihong Peng, Jinhua Wang, Huang Chen, Xiaonan Cong, Ang Chen, Meichun Hu, Min Qin, Haigang Wu, Shuman Gao, Liguo Wang, Xin Wang, Zheng-Fang Yi, Mingyao Liu
Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer. Nature communications 7 (2016)
X Wang, Q Lin, F Lv, N Liu, Y Xu, M Liu, Y Chen, Zheng-Fang Yi
LG-362B targets PML-RARα and blocks ATRA resistance of acute promyelocytic leukemia. Leukemia 30 (7) (2016)

Zheng-Fang Yi.css-eqlu8i{font-size:small;padding-left:4px;} (Z Yi, Zhengfang Yi)

Publication Activity (10 Years)

Top Topics

Top Venues

Zheng-Fang Yi (Z Yi, Zhengfang Yi)